KEGG   PATHWAY: pvp05200
Entry
pvp05200                    Pathway                                
Name
Pathways in cancer - Pteropus vampyrus (large flying fox)
Class
Human Diseases; Cancer: overview
Pathway map
pvp05200  Pathways in cancer
pvp05200

Organism
Pteropus vampyrus (large flying fox) [GN:pvp]
Gene
105288270  APAF1; apoptotic protease-activating factor 1 [KO:K02084]
105288307  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
105288337  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
105288383  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
105288389  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
105288434  CCND3; G1/S-specific cyclin-D3 [KO:K10152]
105288488  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
105288497  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
105288616  RASGRP1; RAS guanyl-releasing protein 1 [KO:K04350]
105288638  RAD51; DNA repair protein RAD51 homolog 1 [KO:K04482]
105288649  DLL4; delta-like protein 4 isoform X2 [KO:K06051]
105288725  MLH1; DNA mismatch repair protein Mlh1 [KO:K08734]
105288737  FGF7; fibroblast growth factor 7 [KO:K04358]
105288758  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
105288781  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
105288850  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
105288866  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X2 [KO:K04515] [EC:2.7.11.17]
105288933  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
105288953  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
105288995  [KO:K04198]
105289063  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
105289068  GNG5; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 [KO:K04542]
105289073  LPAR3; lysophosphatidic acid receptor 3 isoform X2 [KO:K04294]
105289302  STAT4; signal transducer and activator of transcription 4 isoform X1 [KO:K11222]
105289309  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
105289311  CRKL; crk-like protein [KO:K04438]
105289326  MAPK1; mitogen-activated protein kinase 1 isoform X2 [KO:K04371] [EC:2.7.11.24]
105289342  [KO:K00799] [EC:2.5.1.18]
105289343  [KO:K00799] [EC:2.5.1.18]
105289344  [KO:K00799] [EC:2.5.1.18]
105289345  [KO:K00799] [EC:2.5.1.18]
105289423  BCR; breakpoint cluster region protein [KO:K08878] [EC:2.7.11.1]
105289469  IFNGR1; interferon gamma receptor 1 [KO:K05132]
105289628  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
105289673  ITGAV; LOW QUALITY PROTEIN: integrin alpha-V [KO:K06487]
105289767  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
105289813  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
105289863  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
105289903  IL12B; interleukin-12 subunit beta [KO:K05425]
105290023  F2; prothrombin isoform X2 [KO:K01313] [EC:3.4.21.5]
105290030  DDB2; DNA damage-binding protein 2 isoform X1 [KO:K10140]
105290033  NFE2L2; nuclear factor erythroid 2-related factor 2 isoform X1 [KO:K05638]
105290035  SPI1; transcription factor PU.1 [KO:K09438]
105290063  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
105290127  CALM1; calmodulin-1 [KO:K02183]
105290156  WNT16; protein Wnt-16 [KO:K01558]
105290238  SMO; smoothened homolog [KO:K06226]
105290270  IGF1R; insulin-like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
105290328  CTNNB1; catenin beta-1 [KO:K02105]
105290414  ITGA6; integrin alpha-6 isoform X1 [KO:K06485]
105290433  CDC42; cell division control protein 42 homolog isoform X1 [KO:K04393]
105290434  WNT4; protein Wnt-4 [KO:K00408]
105290449  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
105290575  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
105290707  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
105290711  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
105290842  RARB; retinoic acid receptor beta isoform X1 [KO:K08528]
105291003  MITF; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
105291051  WNT10A; protein Wnt-10a [KO:K01357]
105291052  WNT6; protein Wnt-6 isoform X2 [KO:K00445]
105291123  FN1; fibronectin [KO:K05717]
105291153  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
105291179  LAMA2; laminin subunit alpha-2 [KO:K05637]
105291226  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
105291441  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
105291475  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
105291480  TCF7L2; transcription factor 7-like 2 isoform X8 [KO:K04491]
105291512  FZD3; frizzled-3 isoform X1 [KO:K02329]
105291551  EDNRA; endothelin-1 receptor [KO:K04197]
105291589  HHIP; hedgehog-interacting protein [KO:K06231]
105291659  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
105291733  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353]
105291755  PLD2; phospholipase D2 isoform X1 [KO:K01115] [EC:3.1.4.4]
105291866  CRK; adapter molecule crk isoform X1 [KO:K04438]
105291906  TRAF4; TNF receptor-associated factor 4 isoform X1 [KO:K09848]
105291934  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
105292047  MMP2; 72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
105292087  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
105292122  FGF9; fibroblast growth factor 9 [KO:K04358]
105292132  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
105292271  LAMA3; laminin subunit alpha-3 isoform X2 [KO:K06240]
105292284  ROCK1; rho-associated protein kinase 1 isoform X1 [KO:K04514] [EC:2.7.11.1]
105292297  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
105292339  CXCL8; interleukin-8 [KO:K10030]
105292386  FGF5; fibroblast growth factor 5 [KO:K04358]
105292451  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
105292561  MYC; myc proto-oncogene protein [KO:K04377]
105292640  SMAD2; mothers against decapentaplegic homolog 2 isoform X3 [KO:K04500]
105292663  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
105292717  BCL2; apoptosis regulator Bcl-2 isoform X2 [KO:K02161]
105292725  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
105292827  LAMC1; laminin subunit gamma-1 isoform X1 [KO:K05635]
105292869  LAMC2; laminin subunit gamma-2 [KO:K06246]
105292907  MSH6; DNA mismatch repair protein Msh6 [KO:K08737]
105292910  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
105292913  CALM2; calmodulin-2 isoform X1 [KO:K02183]
105292939  EML4; echinoderm microtubule-associated protein-like 4 isoform X1 [KO:K15420]
105292949  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
105292971  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
105293004  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
105293029  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
105293045  EGF; LOW QUALITY PROTEIN: pro-epidermal growth factor [KO:K04357]
105293104  FAS; tumor necrosis factor receptor superfamily member 6 isoform X5 [KO:K04390]
105293112  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
105293152  IL6; interleukin-6 isoform X2 [KO:K05405]
105293163  [KO:K08738]
105293228  KITLG; kit ligand isoform X1 [KO:K05461]
105293259  FGF6; fibroblast growth factor 6 [KO:K04358]
105293261  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
105293279  FGF23; fibroblast growth factor 23 [KO:K22428]
105293290  CCNA1; cyclin-A1 [KO:K06627]
105293353  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
105293400  BIRC5; baculoviral IAP repeat-containing protein 5 [KO:K08731]
105293516  FGFR4; fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
105293547  IL5; interleukin-5 [KO:K05428]
105293549  IL13; LOW QUALITY PROTEIN: interleukin-13 [KO:K05435]
105293550  IL4; interleukin-4 [KO:K05430]
105293567  TCF7; transcription factor 7 isoform X2 [KO:K02620]
105293569  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
105293588  DCC; LOW QUALITY PROTEIN: netrin receptor DCC [KO:K06765]
105293607  WNT8A; protein Wnt-8a [KO:K00714]
105293643  [KO:K04736]
105293770  [KO:K09288]
105293773  KIT; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
105293808  PDGFRA; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
105293851  ESR1; estrogen receptor [KO:K08550]
105293923  E2F3; transcription factor E2F3 isoform X1 [KO:K06620]
105293961  EDN1; endothelin-1 [KO:K16366]
105293998  VEGFD; vascular endothelial growth factor D [KO:K05449]
105294059  KRAS; GTPase KRas isoform X2 [KO:K07827]
105294187  FZD4; frizzled-4 [KO:K02354]
105294251  DAPK2; death-associated protein kinase 2 isoform X1 [KO:K08803] [EC:2.7.11.1]
105294340  ZBTB17; zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
105294373  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
105294383  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 [KO:K04548]
105294412  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
105294429  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
105294446  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
105294458  GLI2; zinc finger protein GLI2 [KO:K16798]
105294526  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
105294552  FZD1; frizzled-1 [KO:K02432]
105294560  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
105294593  PDGFA; platelet-derived growth factor subunit A [KO:K04359]
105294623  RAC1; LOW QUALITY PROTEIN: ras-related C3 botulinum toxin substrate 1 [KO:K04392]
105294710  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
105294764  COL4A3; collagen alpha-3(IV) chain [KO:K06237]
105294766  COL4A4; collagen alpha-4(IV) chain [KO:K06237]
105294948  AGTR1; type-1 angiotensin II receptor [KO:K04166]
105294978  WNT7A; protein Wnt-7a [KO:K00572]
105295002  TRAF5; TNF receptor-associated factor 5 isoform X2 [KO:K09849]
105295029  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
105295054  TPR; nucleoprotein TPR [KO:K09291]
105295145  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
105295155  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
105295168  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
105295219  LAMA4; laminin subunit alpha-4 [KO:K06241]
105295257  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
105295316  LPAR1; lysophosphatidic acid receptor 1 isoform X1 [KO:K04289]
105295411  ITGA3; integrin alpha-3 isoform X2 [KO:K06482]
105295461  ROCK2; LOW QUALITY PROTEIN: rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
105295478  APC; adenomatous polyposis coli protein isoform X3 [KO:K02085]
105295517  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
105295521  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
105295548  FGF20; fibroblast growth factor 20 [KO:K04358]
105295619  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
105295688  CTBP2; C-terminal-binding protein 2 isoform X2 [KO:K04496] [EC:1.1.1.428]
105295712  CUL1; cullin-1 isoform X1 [KO:K03347]
105295757  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
105295829  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
105295851  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
105295861  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
105295874  PTGER3; prostaglandin E2 receptor EP3 subtype isoform X1 [KO:K04260]
105295886  GNG12; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO:K04347]
105295887  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
105295952  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 [KO:K07825]
105295963  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
105296083  [KO:K04632]
105296119  [KO:K06237]
105296141  RALB; ras-related protein Ral-B isoform X2 [KO:K07835]
105296151  COL4A6; collagen alpha-6(IV) chain [KO:K06237]
105296163  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
105296188  RALBP1; ralA-binding protein 1 isoform X1 [KO:K08773]
105296207  LAMA1; LOW QUALITY PROTEIN: laminin subunit alpha-1 [KO:K05637]
105296245  TGFBR1; TGF-beta receptor type-1 isoform X1 [KO:K04674] [EC:2.7.11.30]
105296378  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
105296413  ARHGEF11; rho guanine nucleotide exchange factor 11 [KO:K12331]
105296416  NTRK1; high affinity nerve growth factor receptor [KO:K03176] [EC:2.7.10.1]
105296452  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
105296457  TPM3; tropomyosin alpha-3 chain [KO:K09290]
105296521  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 [KO:K01116] [EC:3.1.4.11]
105296547  FGF17; fibroblast growth factor 17 isoform X1 [KO:K04358]
105296550  NRAS; GTPase NRas isoform X1 [KO:K07828]
105296556  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
105296605  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
105296612  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
105296640  F2RL3; proteinase-activated receptor 4 isoform X2 [KO:K04236]
105296672  IL12RB1; interleukin-12 receptor subunit beta-1 isoform X1 [KO:K05063]
105296814  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
105296843  TXNRD2; thioredoxin reductase 2, mitochondrial isoform X1 [KO:K22182] [EC:1.8.1.9]
105296858  ETS1; protein C-ets-1 [KO:K02678]
105297044  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
105297117  PTCH2; protein patched homolog 2 isoform X1 [KO:K11101]
105297140  [KO:K02649]
105297172  [KO:K00799] [EC:2.5.1.18]
105297181  GSTM4; glutathione S-transferase Mu 4 isoform X1 [KO:K00799] [EC:2.5.1.18]
105297202  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
105297238  BID; BH3-interacting domain death agonist isoform X2 [KO:K04726]
105297256  WNT5B; protein Wnt-5b isoform X1 [KO:K00444]
105297315  BBC3; bcl-2-binding component 3 [KO:K10132]
105297322  CALM3; calmodulin-3 [KO:K02183]
105297437  [KO:K01388] [EC:3.4.24.7]
105297518  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
105297527  WNT10B; protein Wnt-10b [KO:K01357]
105297529  WNT1; proto-oncogene Wnt-1 [KO:K03209]
105297627  WNT11; protein Wnt-11 [KO:K01384]
105297673  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X3 [KO:K19464]
105297699  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
105297702  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
105297749  AXIN2; axin-2 [KO:K04385]
105297807  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 isoform X2 [KO:K04540]
105297815  NOTCH2; neurogenic locus notch homolog protein 2 [KO:K20994]
105297846  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
105297848  BAD; bcl2-associated agonist of cell death [KO:K02158]
105297988  VEGFB; vascular endothelial growth factor B [KO:K16858]
105297993  RASGRP2; RAS guanyl-releasing protein 2 [KO:K12361]
105297999  RELA; transcription factor p65 [KO:K04735]
105298051  EP300; histone acetyltransferase p300 isoform X1 [KO:K04498] [EC:2.3.1.48]
105298053  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
105298078  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
105298116  FZD7; frizzled-7 [KO:K02432]
105298127  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
105298182  NCOA3; nuclear receptor coactivator 3 isoform X1 [KO:K11256] [EC:2.3.1.48]
105298192  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
105298222  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
105298277  BIRC3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
105298278  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
105298360  JAK1; tyrosine-protein kinase JAK1 isoform X1 [KO:K11217] [EC:2.7.10.2]
105298373  IL12RB2; interleukin-12 receptor subunit beta-2 [KO:K05064]
105298385  IL23R; interleukin-23 receptor [KO:K05065]
105298400  FZD5; frizzled-5 [KO:K02375]
105298437  [KO:K05414]
105298440  CDKN2B; cyclin-dependent kinase 4 inhibitor B isoform X4 [KO:K04685]
105298541  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
105298613  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
105298625  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
105298668  LAMC3; laminin subunit gamma-3 [KO:K06247]
105298669  ABL1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
105298674  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]
105298702  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
105298720  BMP2; bone morphogenetic protein 2 [KO:K21283]
105298737  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
105298795  BDKRB1; B1 bradykinin receptor [KO:K03915]
105298796  BDKRB2; B2 bradykinin receptor [KO:K03916]
105298799  JAG1; protein jagged-1 isoform X1 [KO:K06052]
105298901  FOXO1; forkhead box protein O1 [KO:K07201]
105298927  SHH; LOW QUALITY PROTEIN: sonic hedgehog protein [KO:K11988]
105299021  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
105299024  PPARG; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
105299035  VHL; von Hippel-Lindau disease tumor suppressor isoform X1 [KO:K03871]
105299098  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
105299153  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
105299180  [KO:K02183]
105299206  TGFB3; transforming growth factor beta-3 [KO:K13377]
105299213  FOS; proto-oncogene c-Fos [KO:K04379]
105299223  PGF; placenta growth factor isoform X1 [KO:K16859]
105299274  TRAF3; TNF receptor-associated factor 3 isoform X1 [KO:K03174]
105299280  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
105299317  FGF18; fibroblast growth factor 18 [KO:K04358]
105299364  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
105299371  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X3 [KO:K02649]
105299435  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
105299436  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
105299441  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
105299444  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
105299512  IGF2; insulin-like growth factor II [KO:K13769]
105299568  FZD10; frizzled-10 [KO:K02842]
105299581  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
105299605  IL2RG; cytokine receptor common subunit gamma [KO:K05070]
105299625  AR; LOW QUALITY PROTEIN: androgen receptor [KO:K08557]
105299636  VEGFC; vascular endothelial growth factor C [KO:K05449]
105299684  FZD9; frizzled-9 [KO:K02842]
105299734  EPO; erythropoietin [KO:K05437]
105299738  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
105299797  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
105299855  APPL1; DCC-interacting protein 13-alpha [KO:K08733]
105299863  WNT5A; protein Wnt-5a isoform X5 [KO:K00444]
105299891  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
105299958  WNT3A; protein Wnt-3a [KO:K00312]
105299978  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
105300002  WNT9A; protein Wnt-9a [KO:K01064]
105300011  FLT4; vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
105300022  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
105300023  RB1; retinoblastoma-associated protein [KO:K06618]
105300076  RASGRP3; ras guanyl-releasing protein 3 [KO:K12362]
105300146  EGLN2; egl nine homolog 2 isoform X1 [KO:K09592] [EC:1.14.11.29]
105300159  [KO:K04456] [EC:2.7.11.1]
105300188  RASGRP4; RAS guanyl-releasing protein 4 [KO:K12363]
105300221  DLL3; delta-like protein 3 [KO:K06051]
105300252  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
105300255  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
105300269  MET; hepatocyte growth factor receptor isoform X1 [KO:K05099] [EC:2.7.10.1]
105300311  [KO:K06244]
105300315  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
105300342  LAMB4; laminin subunit beta-4 [KO:K06245]
105300344  LAMB1; laminin subunit beta-1 [KO:K05636]
105300424  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
105300436  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
105300631  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
105300647  RASSF5; ras association domain-containing protein 5 [KO:K08015]
105300805  RPS6KA5; ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
105300873  FZD6; frizzled-6 isoform X1 [KO:K02376]
105300975  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
105301000  [KO:K14021]
105301022  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
105301024  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
105301137  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
105301205  IL15; interleukin-15 isoform X1 [KO:K05433]
105301250  ADCY8; adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
105301255  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
105301262  IFNG; interferon gamma [KO:K04687]
105301286  FGF10; fibroblast growth factor 10 [KO:K04358]
105301304  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
105301329  MDM2; E3 ubiquitin-protein ligase Mdm2 [KO:K06643] [EC:2.3.2.27]
105301330  COL4A1; collagen alpha-1(IV) chain [KO:K06237]
105301331  COL4A2; collagen alpha-2(IV) chain isoform X1 [KO:K06237]
105301374  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
105301444  LAMA5; laminin subunit alpha-5 [KO:K06240]
105301455  BIRC7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
105301506  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
105301565  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
105301628  ARNT2; aryl hydrocarbon receptor nuclear translocator 2 isoform X7 [KO:K15589]
105301701  CTNNA3; catenin alpha-3 [KO:K05691]
105301742  FLT3LG; fms-related tyrosine kinase 3 ligand isoform X1 [KO:K05454]
105301762  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
105301799  FGF21; fibroblast growth factor 21 [KO:K22429]
105301849  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
105301871  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
105302044  WNT7B; protein Wnt-7b [KO:K00572]
105302100  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
105302177  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
105302193  F2R; proteinase-activated receptor 1 [KO:K03914]
105302208  IL2; interleukin-2 [KO:K05429]
105302217  CCNA2; cyclin-A2 [KO:K06627]
105302250  FGF22; fibroblast growth factor 22 [KO:K04358]
105302259  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
105302383  RHOA; transforming protein RhoA [KO:K04513]
105302419  LAMB2; laminin subunit beta-2 [KO:K06243]
105302420  [KO:K06243]
105302449  BRCA2; LOW QUALITY PROTEIN: breast cancer type 2 susceptibility protein [KO:K08775]
105302452  [KO:K04634]
105302532  IKBKG; NF-kappa-B essential modulator [KO:K07210]
105302552  STAT6; signal transducer and activator of transcription 6 isoform X1 [KO:K11225]
105302575  IL23A; interleukin-23 subunit alpha [KO:K05426]
105302576  STAT2; signal transducer and activator of transcription 2 isoform X2 [KO:K11221]
105302600  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
105302655  SP1; transcription factor Sp1 isoform X1 [KO:K04684]
105302718  GNG4; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 isoform X1 [KO:K04541]
105302767  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta [KO:K04515] [EC:2.7.11.17]
105302792  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
105302799  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
105302827  TXNRD3; thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
105302941  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
105302950  IL7; interleukin-7 isoform X1 [KO:K05431]
105302953  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
105303008  ITGB1; integrin beta-1 [KO:K05719]
105303011  CUL2; cullin-2 isoform X2 [KO:K03870]
105303095  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
105303098  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
105303138  ELOB; elongin-B [KO:K03873]
105303182  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
105303192  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
105303207  RALA; ras-related protein Ral-A [KO:K07834]
105303216  GLI3; transcriptional activator GLI3 isoform X1 [KO:K06230]
105303252  AXIN1; axin-1 isoform X1 [KO:K02157]
105303281  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 isoform X4 [KO:K04547]
105303367  IL4R; interleukin-4 receptor subunit alpha [KO:K05071]
105303436  JUN; transcription factor AP-1 [KO:K04448]
105303453  WNT3; proto-oncogene Wnt-3 [KO:K00312]
105303454  WNT9B; protein Wnt-9b [KO:K01064]
105303480  FZD2; frizzled-2 [KO:K02235]
105303529  ITGA2B; integrin alpha-IIb [KO:K06476]
105303584  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
105303599  DVL1; segment polarity protein dishevelled homolog DVL-1 [KO:K02353]
105303606  CALML6; calmodulin-like protein 6 [KO:K02183]
105303719  DLL1; delta-like protein 1 isoform X3 [KO:K06051]
105303754  MSH3; DNA mismatch repair protein Msh3 isoform X1 [KO:K08736]
105303857  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
105303895  JAG2; protein jagged-2 [KO:K21635]
105303899  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
105303970  BCL2L11; bcl-2-like protein 11 isoform X1 [KO:K16341]
105303986  PAX8; paired box protein Pax-8 isoform X2 [KO:K09293]
105304017  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 isoform X1 [KO:K07299]
105304170  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
105304241  XIAP; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
105304277  E2F1; transcription factor E2F1 [KO:K17454]
105304566  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
105304619  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
105304647  FGF8; fibroblast growth factor 8 isoform X1 [KO:K04358]
105304667  WNT8B; protein Wnt-8b [KO:K00714]
105304705  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
105304799  [KO:K00799] [EC:2.5.1.18]
105304800  [KO:K00799] [EC:2.5.1.18]
105304810  [KO:K00799] [EC:2.5.1.18]
105305205  KIF7; kinesin-like protein KIF7 [KO:K18806]
105305275  NOTCH4; neurogenic locus notch homolog protein 4 isoform X3 [KO:K20996]
105305408  FH; fumarate hydratase, mitochondrial isoform X1 [KO:K01679] [EC:4.2.1.2]
105305418  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
105305459  ARAF; serine/threonine-protein kinase A-Raf isoform X8 [KO:K08845] [EC:2.7.11.1]
105305461  ELK1; ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
105305503  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
105305539  IL13RA1; interleukin-13 receptor subunit alpha-1 [KO:K05076]
105305601  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
105305625  EPOR; erythropoietin receptor [KO:K05079]
105305756  CDH1; cadherin-1 isoform X1 [KO:K05689]
105305876  IL12A; interleukin-12 subunit alpha [KO:K05406]
105305877  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
105305933  HRAS; GTPase HRas isoform X1 [KO:K02833]
105305980  MECOM; MDS1 and EVI1 complex locus protein EVI1 [KO:K04462] [EC:2.1.1.367]
105306010  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
105306014  EGLN1; egl nine homolog 1 [KO:K09592] [EC:1.14.11.29]
105306022  AGT; angiotensinogen [KO:K09821]
105306141  [KO:K04361] [EC:2.7.10.1]
105306294  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
105306315  JUP; junction plakoglobin isoform X3 [KO:K10056]
105306335  [KO:K11223]
105306336  [KO:K11224]
105306395  HES1; transcription factor HES-1 [KO:K06054]
105306473  [KO:K08803] [EC:2.7.11.1]
105306550  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
105306557  [KO:K23790]
105306558  [KO:K23790]
105306578  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
105306731  KNG1; kininogen-1 isoform X1 [KO:K03898]
105306742  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
105306744  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
105306822  PML; protein PML isoform X3 [KO:K10054] [EC:2.3.2.-]
105306915  PTCH1; protein patched homolog 1 isoform X3 [KO:K06225]
105306994  CTNNA1; catenin alpha-1 [KO:K05691]
105307100  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
105307123  [KO:K22603]
105307126  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
105307127  [KO:K22603]
105307128  [KO:K04503]
105307139  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
105307149  FZD8; frizzled-8 [KO:K02375]
105307158  GNG14; putative guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-14 [KO:K04347]
105307207  NQO1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
105307215  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
105307274  GNGT2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 [KO:K04549]
105307342  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
105307376  GLI1; zinc finger protein GLI1 isoform X1 [KO:K16797]
105307393  CDK4; cyclin-dependent kinase 4 isoform X2 [KO:K02089] [EC:2.7.11.22]
105307445  SKP2; S-phase kinase-associated protein 2 isoform X2 [KO:K03875]
105307475  FADD; FAS-associated death domain protein [KO:K02373]
105307498  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
105307521  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
105307523  RARA; retinoic acid receptor alpha isoform X1 [KO:K08527]
105307575  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
105307737  IL2RA; interleukin-2 receptor subunit alpha [KO:K05068]
105307744  IL15RA; interleukin-15 receptor subunit alpha [KO:K05074]
105307748  PTK2; focal adhesion kinase 1 [KO:K05725] [EC:2.7.10.2]
105307927  ITGA2; integrin alpha-2 isoform X1 [KO:K06481]
105307945  TGFB1; transforming growth factor beta-1 [KO:K13375]
105307968  GNG10; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 [KO:K04545]
105308004  [KO:K04737]
105308006  [KO:K05066]
105308251  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
105308299  [KO:K08041] [EC:4.6.1.1]
105308374  MAX; protein max isoform X1 [KO:K04453]
105308420  RUNX1T1; protein CBFA2T1 isoform X1 [KO:K10053]
105308466  WNT2; protein Wnt-2 [KO:K00182]
105308501  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
105308507  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
105308555  ESR2; estrogen receptor beta isoform X2 [KO:K08551]
105308691  HIF1A; hypoxia-inducible factor 1-alpha isoform X2 [KO:K08268]
105308762  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
105308799  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
105308818  [KO:K19662] [EC:2.7.11.13]
105308867  CBL; E3 ubiquitin-protein ligase CBL isoform X1 [KO:K04707] [EC:2.3.2.27]
105308889  FGF16; fibroblast growth factor 16 [KO:K04358]
105308956  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X2 [KO:K00922] [EC:2.7.1.153]
105309143  [KO:K05414]
105309144  [KO:K05414]
105309148  [KO:K05414]
105309193  RET; proto-oncogene tyrosine-protein kinase receptor Ret isoform X4 [KO:K05126] [EC:2.7.10.1]
105309232  BMP4; bone morphogenetic protein 4 isoform X1 [KO:K04662]
105309351  PTGER2; prostaglandin E2 receptor EP2 subtype isoform X1 [KO:K04259]
105309385  GNG2; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 [KO:K07826]
105309400  ADCY4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
105309462  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
105309511  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
105309535  SOS2; son of sevenless homolog 2 [KO:K03099]
105309657  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
105309663  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
105309689  CALML4; LOW QUALITY PROTEIN: calmodulin-like protein 4 [KO:K02183]
105309743  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
105309746  SMAD3; mothers against decapentaplegic homolog 3 [KO:K23605]
105309827  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
105309888  [KO:K04358]
105310003  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
105310269  [KO:K04543]
105310714  IGF1; insulin-like growth factor I isoform X3 [KO:K05459]
105310743  HSP90B1; endoplasmin [KO:K09487]
105310803  [KO:K05454]
105310817  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
105311175  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
105311216  [KO:K04685]
105311363  FGF4; fibroblast growth factor 4 [KO:K04358]
105311493  IL2RB; interleukin-2 receptor subunit beta isoform X1 [KO:K05069]
105311532  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X2 [KO:K07860]
105311618  TFG; protein TFG isoform X3 [KO:K09292]
111728731  ELOC; elongin-C [KO:K03872]
111728746  [KO:K14021]
111744611  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 [KO:K04544]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
pvp03320  PPAR signaling pathway
pvp04010  MAPK signaling pathway
pvp04020  Calcium signaling pathway
pvp04024  cAMP signaling pathway
pvp04060  Cytokine-cytokine receptor interaction
pvp04066  HIF-1 signaling pathway
pvp04110  Cell cycle
pvp04115  p53 signaling pathway
pvp04150  mTOR signaling pathway
pvp04151  PI3K-Akt signaling pathway
pvp04210  Apoptosis
pvp04310  Wnt signaling pathway
pvp04330  Notch signaling pathway
pvp04340  Hedgehog signaling pathway
pvp04350  TGF-beta signaling pathway
pvp04370  VEGF signaling pathway
pvp04510  Focal adhesion
pvp04512  ECM-receptor interaction
pvp04520  Adherens junction
pvp04630  JAK-STAT signaling pathway
pvp04915  Estrogen signaling pathway
KO pathway
ko05200   

DBGET integrated database retrieval system